arrow
P

Peter K. Bode

swiss federal institutes of technology domain
H指数:34
被引数:4,759

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target

CIC::DUX4易位的肉瘤来源类器官鉴定MCL1为治疗靶点

2025-08-210
OAAI
Donor adipose-derived stromal cells are vasoprotectant but unable to revert acute rejection in rodent vascularized composite allotransplants

供者脂肪来源基质细胞具有血管保护作用,但无法逆转啮齿类血管化复合组织移植中的急性排斥反应。

2025-04-280
OA
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer

AXL在融合阳性小儿横纹肌肉瘤中的作用评估将小分子抑制剂Bemcentinib (BGB324) 确定为有效的化学增敏剂

2024-03-121
OAAI
Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup

泌尿生殖道胚胎性横纹肌肉瘤的临床病理和分子分析: 一个独特的DICER1-associated亚组的证据

2021-08-0135
OAAI